Location History:
- Old Lyme, CT (US) (2016)
- Bridport, VT (US) (2017)
Company Filing History:
Years Active: 2016-2017
Title: Kevin Barry Bahnck: Innovator in Prostaglandin Research
Introduction
Kevin Barry Bahnck is a notable inventor based in Old Lyme, CT (US). He has made significant contributions to the field of pharmacology, particularly in the development of antagonists for the prostaglandin EP3 receptor. With a total of 2 patents to his name, Bahnck's work is pivotal in advancing therapeutic options for various medical conditions.
Latest Patents
Bahnck's latest patents focus on antagonists of the prostaglandin EP3 receptor. These patents detail processes for creating these antagonists and methods for administering them to mammals in need. His innovative approach aims to provide new avenues for treatment in areas where prostaglandin signaling plays a critical role.
Career Highlights
Kevin Barry Bahnck is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Bahnck has had the opportunity to work alongside esteemed colleagues such as David James Edmonds and Kentaro Futatsugi. These collaborations enhance the research environment and foster innovation within the team.
Conclusion
Kevin Barry Bahnck's contributions to the field of pharmacology through his patents on prostaglandin EP3 receptor antagonists highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.